A consultation regarding the reform of the UK's Cancer Drugs Fund (CDF) has been launched.
Established in 2011, the CDF is used to fund cancer drugs that are yet to be approved by the National Institute for Health and Care Excellence NICE.
As of 2016, a new version of the CDF will be launched and the exact nature of this will be discussed in the consultation.
NHS England and NICE have released draft proposals for the new fund and are now seeking opinions on these over the next 12 weeks.
The main crux of the proposals is that the CDF will become a 'managed access' fund, providing access to drugs that appear promising, but have uncertain evidence bases to support a recommendation for routine commissioning.
Simon Stevens, NHS England chief executive, commented: "Our joint proposals will ensure that the CDF is used to provide patients with promising medicines at a cost which reflects the uncertainty about their effectiveness and cost effectiveness and, at the same time, generate additional data to help the NHS make a longer term decision on whether and how to use them."
Find the nearest Barchester care home.